QSBS Section 1202 Exclusion on a $5M Startup Exit: How Founders Exclude Up to $10M in Federal Capital Gains

The $1.18M question: QSBS vs non-QSBS on a $5M sale

A Denver founder sells her C-corp SaaS company for $5M in 2026. She founded the company in 2019, invested $50,000 at incorporation, and has held her shares for seven years. The company had $2M in gross assets when it issued her stock. She files single.

That’s $1,178,100 in federal tax saved. The § 1202 exclusion eliminates LTCG, NIIT, and (for post-2010 stock) AMT on the excluded portion. No other provision in the Internal Revenue Code produces this magnitude of tax-free gain on a single transaction for a founder-level taxpayer.

Colorado has a 4.4% flat state income tax that applies to the gain separately — but if this founder were in Texas, Florida, or any of the nine no-income-tax states, the total tax bill would literally be $0.

The five eligibility tests: all five must be true at issuance

§ 1202 is generous, but the eligibility gate is narrow. All five tests must be satisfied at the time the stock is issued to you:

Test 1: C-corporation at issuance

The company must be a domestic C-corporation when it issues the stock. S-corps, LLCs, and partnerships do not qualify. If a company converts from an LLC to a C-corp, the QSBS clock starts at conversion — prior holding time in the LLC does not count. This is the most common planning mistake: founders who operate as an LLC for years, convert to C-corp for a funding round, and assume their holding period extends back to founding.

Test 2: Active trade or business (qualified trade or business requirement)

At least 80% of the corporation’s assets must be used in the active conduct of a qualified trade or business during substantially all of the taxpayer’s holding period. Excluded businesses: professional services (health, law, engineering, accounting, consulting, financial services, brokerage, athletics), banking, insurance, farming, mining, hospitality (hotels, restaurants, motels).

The part most founders miss: “consulting” is excluded. A SaaS company that sells software qualifies. A company that primarily sells consulting services delivered by its employees does not — even if it also has a software product. The IRS looks at where the revenue comes from, not what the company calls itself. If more than 20% of assets are tied to excluded activities, the stock fails the test.

Test 3: Original issuance

You must acquire the stock directly from the corporation — at founding, through a capital contribution, or by exercising options. Stock purchased on a secondary market, acquired through a broker, or bought from another shareholder does not qualify. The “original issuance” requirement exists to ensure the capital went to the company, not to a prior holder.

Stock from exercised ISOs or NSOs qualifies if the underlying shares meet the other four tests. The five-year clock starts at exercise, not at the option grant date.

Test 4: $50M gross-asset cap

The corporation’s aggregate gross assets must not exceed $50M at any time before the issuance and immediately after the issuance. “Gross assets” means the tax basis of all corporate assets (cash + property at adjusted basis), not fair market value. This favors asset-light companies: a SaaS startup with $3M in cash, $200K in equipment, and a $40M enterprise value still has only ~$3.2M in gross assets.

Critical timing: the test locks at issuance. If the company later raises a $100M Series C and gross assets balloon to $80M, your shares still qualify — you received them when the company was small. But any new shares issued after the company crosses $50M do not qualify for those later recipients.

Test 5: Five-year holding period

You must hold the stock for at least five years from the date of issuance (or exercise, for options). Selling before five years forfeits the exclusion entirely on those shares. There is no partial credit for holding four years and eleven months.

For founders who receive stock at incorporation, this is usually easy — most startups take 5–10 years to reach a liquidity event. For employees who exercise options late in the company’s life, the five-year clock can be the binding constraint.

Partial workaround: IRC § 1045 allows a taxpayer who sells QSBS before five years to roll the gain into new QSBS within 60 days, deferring the gain and tacking the holding period. This is narrow — the replacement stock must itself be QSBS in a different qualifying company — but it exists for founders who exit early and reinvest.

The per-issuer cap: $10M or 10× basis, whichever is greater

The exclusion is capped at the greater of $10M or 10× the taxpayer’s adjusted basis in the stock, per issuer. For most founders with small initial investments, the $10M flat cap is the binding number:

The 10× basis rule matters for angel investors who write larger checks. An investor who puts $2M into a qualifying C-corp gets a $20M exclusion cap — double the flat $10M. For our Denver founder with $50K basis, the cap is $10M, and her $4.95M gain falls well within it.

Stacking: how to multiply the $10M cap with a spouse or trust

The $10M cap is per taxpayer, per issuer. Each separate taxpayer who holds QSBS gets their own cap. This creates three stacking strategies:

Strategy 1: Spousal gift

Gift QSBS shares to your spouse before the sale. The spouse receives a tacked holding period (your original holding period transfers) and their own $10M cap. A married couple can exclude up to $20M of gain from a single issuer. The gift itself is not a taxable event (unlimited marital deduction under IRC § 2523). This is the simplest and most commonly used stacking method.

Strategy 2: Non-grantor trusts

Each non-grantor trust that holds QSBS gets its own $10M exclusion. A founder who establishes two non-grantor trusts (e.g., for children) and gifts shares to each trust before the sale adds two more $10M caps: founder ($10M) + spouse ($10M) + trust 1 ($10M) + trust 2 ($10M) = $40M of excludable gain. The trusts must be non-grantor — grantor trusts are treated as the grantor for tax purposes and share the grantor’s cap.

Strategy 3: Gifts to family members

Gifting shares to adult children or other family members (outright, not in trust) creates additional caps. Each recipient gets their own $10M exclusion. The annual gift exclusion is $19,000 per donee (2026), or the lifetime exemption ($13.99M) can shelter larger transfers. The recipient’s holding period tacks from the donor’s original acquisition date.

The window closes at the sale. All gifts, trust funding, and spousal transfers must be completed before the transaction closes. Once the sale is executed, the gain is realized by whoever holds the shares at that moment. This is why QSBS stacking must be planned months or years before a liquidity event — not during due diligence.

State conformity: the map that changes everything

The federal exclusion is only half the picture. State tax treatment of QSBS gains varies dramatically:

California is the big one. A California-resident founder selling $5M of QSBS with a $50K basis owes approximately $651,000 in California state tax (13.3% top rate on $4.89M of gain after California’s own deductions). Federal bill: $0. California’s non-conformity means the total tax on the same sale is $651K for a San Francisco founder vs. $0 for an Austin founder. That differential alone exceeds most retirees’ annual living expenses.

New Jersey (top rate 10.75%), Pennsylvania (3.07% flat), Mississippi (5%), and Alabama (5%) also do not conform, though the dollar impact is smaller than California’s.

Planning implication: founders with QSBS who anticipate a sale within 2–3 years should evaluate state residency as a planning variable. Moving from California to a conforming or no-tax state before the sale is a legitimate strategy — but California’s FTB is aggressive about challenging residency changes within 18 months of a liquidity event. Clean breaks (selling the home, moving the family, establishing domicile) are essential if this path is pursued.

AMT interaction: pre-2013 stock vs post-2010 stock

The AMT treatment of QSBS has changed over time based on when the stock was acquired:

For founders with stock acquired after September 27, 2010 — which includes nearly every startup founded in the last 15 years — the AMT flag is irrelevant. The exclusion is 100% with no AMT preference, no NIIT, and no LTCG on the excluded gain.

Where this still matters: angel investors or early employees who acquired stock in companies founded before 2009 and have held continuously. If you hold pre-2009 QSBS, 7% of the excluded gain (the portion excluded from regular tax) becomes an AMT preference item. On a $5M gain with 50% exclusion, that’s 7% × $2.5M = $175,000 added to AMT income. Whether that triggers actual AMT liability depends on your AMT exemption and other preference items.

Scenario: the founder who didn’t plan early enough

A San Francisco founder of a SaaS company sells her stock for $40M. She founded the C-corp in 2018 with $50,000 of basis. The company crossed $50M in gross assets in 2021. She held the shares from 2018 founding through the 2026 sale — eight years.

• Gain: $40M − $50K basis = $39.95M
• § 1202 cap: greater of $10M or 10× $50K ($500K). Cap = $10M.
• Federal exclusion: 100% of the first $10M is excluded (post-9/27/2010 stock).
• Taxable federal gain: $29.95M.
• Federal LTCG @ 20% + NIIT @ 3.8%: ~$7.13M
• California (does not conform): $40M × 13.3% top rate = ~$5.32M

The decision lever that mattered: setting up a non-grantor trust in Delaware two years before the sale would have stacked another $10M of QSBS exclusion (each non-grantor trust gets its own $10M cap). That’s roughly $2.38M of additional federal savings. A spousal gift would have added yet another $10M cap. Between spouse + one trust, the excluded amount could have been $30M instead of $10M — saving an additional $4.76M in federal tax.

The trust setup costs ~$10K–$25K with a qualified estate attorney. The planning window closed when she didn’t structure before the sale.

Stock options and QSBS: ISO vs NSO

Startup employees often receive ISOs or NSOs rather than founder stock. Both can produce QSBS-eligible shares, but the mechanics differ:

The NSO basis advantage is underappreciated: because NSO holders pay ordinary income tax on the spread at exercise, their QSBS basis includes that spread. Higher basis means a higher 10× basis cap. An employee who exercises NSOs when the spread is $2M has a QSBS basis of $2M + strike price, producing a 10× cap of $20M+. The same employee with ISOs has a basis equal to the strike price only — typically a much smaller number.

For a deeper comparison of the two grant types and their tax treatment at various spread levels, see NSO vs ISO: which saves more tax at $250K, $500K, and $1M spreads.

The deal structure trap: asset sale kills QSBS

§ 1202 applies to sales of stock. If the acquirer structures the deal as an asset purchase (buying the company’s assets rather than its stock), the seller does not sell QSBS — the corporation sells assets and distributes proceeds, which are taxed as ordinary income, capital gains, and depreciation recapture at the corporate and individual levels. The exclusion is lost entirely.

Buyers prefer asset sales because they get a stepped-up basis in the acquired assets (more depreciation and amortization going forward). Sellers with QSBS should push for a stock sale. The negotiation often comes down to whether the seller will accept a lower price in a stock sale vs. a higher price in an asset sale where the QSBS exclusion evaporates.

The asset-sale vs stock-sale negotiation is one of the most consequential deal-structure decisions for founders with qualifying QSBS. A founder with $5M of QSBS who agrees to an asset sale to get a 5% price premium ($250K) but loses $1.18M of § 1202 savings has made a $930K mistake.

Section 1045: the rollover for early exits

If you sell QSBS before the five-year mark, IRC § 1045 offers a partial escape. You can defer the gain by reinvesting the proceeds into new QSBS within 60 days. The holding period of the old stock tacks onto the new stock, so if you held the original shares for three years and roll into new QSBS, you only need two more years to reach the five-year threshold for the new shares.

Constraints: the replacement stock must be QSBS in a different qualifying C-corporation. You cannot roll proceeds back into the same company. The new company must independently meet all five eligibility tests. This is a narrow tool, but it matters for serial founders who exit one startup and reinvest in another.

Record-keeping: the documentation that saves the exclusion

§ 1202 failures are overwhelmingly documentation failures, not eligibility failures. The IRS can (and does) challenge QSBS exclusions on audit, and the burden of proof is on the taxpayer. Keep these records from day one:

• Articles of incorporation confirming C-corp status at the time of stock issuance
• Stock purchase agreement showing original issuance (not secondary purchase)
• Board resolutions authorizing the stock issuance
• Corporate tax returns (Form 1120) for the year of issuance showing gross assets below $50M
• Financial statements from the issuance date confirming the gross-asset calculation
• Proof of qualified active business: revenue breakdown showing <20% from excluded activities
• Holding period documentation: brokerage statements, cap table records, or stock ledger entries showing continuous ownership for 5+ years

For companies that convert to C-corp status from LLC or S-corp, the conversion date documentation is especially critical — the QSBS holding period starts at conversion, and the IRS will look for evidence that the entity was a C-corp at the time of issuance.

The bottom line

IRC § 1202 is the single largest tax break available to founders of qualifying C-corporations. On our $5M worked example, the exclusion saves $1,178,100 in federal tax — the entire gain disappears from the federal return. The five eligibility tests are strict but straightforward for most venture-backed SaaS, biotech, and technology companies. The planning levers are stacking (spouse + trusts to multiply the $10M cap), deal structure (stock sale, not asset sale), and state residency (California taxes the full gain; Texas and Florida do not).

The decisions that determine whether you capture or forfeit this exclusion are made at three points: (1) entity formation (C-corp from day one, not a conversion after crossing $50M), (2) pre-sale structuring (spousal gifts and trusts funded before the deal closes), and (3) deal negotiation (stock sale structure preserved). All three happen before the closing table. By the time the wire hits, the § 1202 outcome is already locked in.